NTRA Q1 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$152M+62.0% YoY

Gross Profit

$86M56.1% margin

Operating Income

-$63M-41.4% margin

Net Income

-$64M-41.9% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+35.5%

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$85M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$894M

Total Liabilities

$521M

Stockholders' Equity

$372M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152M	$94M	+62.0%
Gross Profit	$86M	$49M	+74.4%
Operating Income	-$63M	-$35M	-80.7%
Net Income	-$64M	-$35M	-80.5%

Revenue Segments

Product

$118M73%

Licensing And Other

$34M21%

Other Licensing And Other Revenue

$10M6%

Geographic Segments

U

$145M95%

E M E A

$4M3%

Other Geographic Areas

$2M1%

Americas Excluding Us

$813,0001%